The price of this share is at 7,64$, In this post we are going to talk about the listed company Fulcrum Therapeutics Inc, its leaders are Bryan E Stuart (President, Chief Executive Officer, COO & Director), Christopher J Morabito (Chief Medical Officer), Christopher Moxham (Chief Scientific Officer), Mani Sundararajan (Senior Vice President-Technical Operations), Peter Thomson (Chief Financial Officer & VP-Finance & Accounting), they lead it to work in Biotechnology: Pharmaceutical Preparations especially in the North America region.
The closing price of the stock yesterday was desconocido$.
The current range on the same day is from 7,23$ - 7,66$, with a percentage difference of 7,45$ quite wide that helps to be able to do day trading.
The company has an annual revenue of desconocido.
The last registered opening is of desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
The EPS, or net profit divided by the number of shares in progress, tells us with a high value that we must enter and with a low value that we must leave, it is a result of how the company has done in the last year.
Buscar
